A5045529492- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Aortic Disease and Treatment Approaches
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- COVID-19 Clinical Research Studies
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Cardiac, Anesthesia and Surgical Outcomes
- Peripheral Artery Disease Management
- Long-Term Effects of COVID-19
- Lipoproteins and Cardiovascular Health
- Cardiomyopathy and Myosin Studies
- Mechanical Circulatory Support Devices
- Cardiovascular Syncope and Autonomic Disorders
- COVID-19 and Mental Health
- Pericarditis and Cardiac Tamponade
- Adipokines, Inflammation, and Metabolic Diseases
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Comparative constitutional jurisprudence studies
- Cardiac Arrest and Resuscitation
- Political Dynamics in Latin America
- Veterinary Orthopedics and Neurology
- Chronic Disease Management Strategies
- Diagnosis and Treatment of Venous Diseases
Hospital Clínico Universitario de Valladolid
2019-2025
Centro de Investigación en Red en Enfermedades Cardiovasculares
2020-2025
Centro de Investigación Biomédica en Red
2020-2025
Instituto de Salud Carlos III
2024-2025
Universidad de León
2015
Hospital Universitario Virgen de las Nieves
2014
There are limited head-to-head randomised trials comparing the performance of different transcatheter heart valves (THVs).
Introduction: Coronavirus disease 2019 (COVID-19) is a systemic characterized by disproportionate inflammatory response in the acute phase. This study sought to identify clinical sequelae and their potential mechanism. Methods: We conducted prospective single-center (NCT04689490) of previously hospitalized COVID-19 patients with without dyspnea during mid-term follow-up. An outpatient group was also evaluated. They underwent serial testing cardiopulmonary exercise test (CPET), transthoracic...
Transcatheter aortic valve replacement (TAVR) in patients with bicuspid (BAV) stenosis is technically challenging and burdened by an increased risk of paravalvular regurgitation (PVR).
We aimed to describe hemodynamic performance and clinical outcomes at 30-day follow-up of the balloon-expandable (BE) Myval transcatheter heart valve (THV) in low-risk patients.The results next-generation BE THV aortic stenosis (AS) patients are still unknown.Retrospective registry performed nine European centers including with low predicted operative mortality risk according Society thoracic surgeons (STS) system for cardiac evaluation (EuroSCORE-II) scores.Between September 2019 February...
CONSIDERACIONES ÉTICASComo esta es la
Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence unknown. Methods (2): We conducted case-control analysis nested in prospective cohort study. Individuals were recruited from August 2020 December 2020. Patients grouped according the presence or absence of long-COVID for three months COVID-19 resolution. compared demographic data,...
The vast majority of transcatheter valve-in-valve (ViV) mitral procedures have been reported with the SAPIEN family. We aimed to report preliminary experience Myval balloon-expandable device in this setting.
STRUCTURED ABSTRACT Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the sole causative agent of infectious disease-19 (COVID-19). Methods We performed a retrospective single-center study consecutively admitted patients between March 1 st and May 15 th, 2020, with definitive diagnosis SARS-CoV-2 infection. The primary end-point was to evaluate association lipid markers 30-days all-cause mortality in COVID-19. Results A total 654 were enrolled, an estimated 30-day...
The recurrence of syncope after valve intervention in severe aortic stenosis (SAS) and its impact on outcome are unknown. We hypothesised that exertion will disappear intervention, whereas at rest might recur. Our aim has been to describe the patients with SAS undergoing replacement mortality.Double-centre observational registry 320 consecutive symptomatic without other disease and/or coronary artery who underwent were discharged alive. All-cause mortality cardiovascular considered events.53...
Background: Quantitative flow ratio (QFR) virtual angioplasty with pre-PCI residual QFR showed better results compared an angiographic approach to assess post-PCI functional results. However, correlation and fractional reserve (FFR) is lacking. Methods: A multicenter prospective study including consecutive patients angiographically 50–90% coronary lesions positive All were evaluated QFR, hyperemic non-hyperemic pressure ratios (NHPR) before after the index PCI. Pre-PCI (virtual angioplasty)...
We report the case of a 6-month-old infant who presented with complete duplication large intestine, debuting clinically acute abdomen and severe metabolic disorders. discuss pathogenesis morphology lesions, diagnostic difficulties peculiarities surgical treatment.
Due to improvement in the management of patients with congenital heart disease (CHD), likelihood their survival adulthood is increasing. A relevant population suffers end-stage right ventricular failure (RVF) 3rd-4th decade life. Hence, transplantation still gold standard treatment failure, mechanical circulatory assistance has become a valuable tool bridging transplant or definitive therapy. Use implantable short-term long-term devices reported by others. However, within this clinical...